MedPath

PRP Prevents Recurrence of Intrauterine Adhesions

Not Applicable
Conditions
Intrauterine Adhesion
Interventions
Procedure: gel
Procedure: Platelet-rich plasma
Registration Number
NCT03629132
Lead Sponsor
Yanhong Deng
Brief Summary

Effect of platelet-rich plasma (PRP) on uterine scar fibrosis, endometrial receptivity and pregnancy outcome in patients with severe intrauterine adhesions

Detailed Description

1. Inclusion criteria: patients with intrauterine adhesions (AFS score \>9 points); age 21 to 40 years old, with fertility requirements.

2. Study design:prospective, randomized controlled cohort study, patients with intrauterine adhesions were randomized into two groups, the control group and the intervention group (intraoperative and postoperative 1 week postoperative PRP). The surgical procedures and postoperative medication regimens were the same.

3. Compare the biochemical pregnancy rate, clinical pregnancy rate, abortion rate and live birth rate after hysteroscopic resection in PRP group and control group, and explore the effect of PRP on pregnancy outcome after intrauterine adhesion.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
60
Inclusion Criteria

Patients with intrauterine adhesions (AFS score >9 points); age 21 to 40 years old, with fertility requirements -

Exclusion Criteria

Endometrial tuberculosis, endometrial polyps, uterine submucosal fibroids, endometrial hyperplasia, endometrial malignant lesions, premature ovarian failure, chromosomal abnormalities

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
GelgelSelf-crosslinking sodium hyaluronate gel
PRPPlatelet-rich plasmaPlatelet-rich plasma
Primary Outcome Measures
NameTimeMethod
AFS score1 year

AFS score

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath